UNRELIEVED STRESS CONTRIBUTES TO HIGHER LEVELS OF CO-OCCURRING CANCER-RELATED COGNITIVE IMPAIRMENT (CRCI) AND ANXIETY IN OUTPATIENTS RECEIVING CHEMOTHERAPY

被引:0
|
作者
Oppegaard, Kate [1 ]
Miaskowski, Christine [1 ]
Cooper, Bruce [1 ]
Paul, Steven [1 ]
Shin, Joosun [1 ]
Harris, Carolyn [1 ]
Calvo-Schimmel, Alejandra [1 ]
Kober, Kord [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P286
引用
收藏
页码:E161 / E161
页数:1
相关论文
共 9 条
  • [1] Adverse Childhood Experiences and Higher Levels of Stress Are Associated With the Co-occurrence of Cancer-Related Cognitive Impairment and Anxiety
    Oppegaard, Kate R.
    Mayo, Samantha J.
    Armstrong, Terri S.
    Kober, Kord M.
    Anguera, Joaquin
    Hammer, Marilyn J.
    Levine, Jon D.
    Conley, Yvette P.
    Paul, Steven
    Cooper, Bruce
    Miaskowski, Christine
    SEMINARS IN ONCOLOGY NURSING, 2023, 39 (06)
  • [2] Cancer-related cognitive impairment (CRCI) in women with early breast cancer: A prospective screening study prior to and following chemotherapy
    Ibrahim, R. A. E.
    El Gowily, A. G.
    El Husseiny, G.
    Elsalamawy, D.
    Badawy, A. Ashour
    BREAST, 2025, 80
  • [3] Phase II study of exercise and low-dose ibuprofen for cancer-related cognitive impairment (CRCI) during chemotherapy.
    Janelsins, Michelle Christine
    Shayne, Michelle
    Huston, Alissa
    Doyle, Kassandra
    Culakova, Eva
    Porto, Michelle
    Lin, Po-Ju
    Magnuson, Allison
    Tejani, Mohamedtaki Abdulaziz
    Dunne, Richard Francis
    Dhakal, Ajay
    Hezel, Aram F.
    Noel, Marcus Smith
    Morrow, Gary R.
    Mohile, Supriya Gupta
    Mustian, Karen Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Deranged cytokine levels are linked to cancer-related cognitive impairment in lymphoma patients receiving R-CHOP chemotherapy
    Mishra, Pinki
    Bhurani, Dinesh
    Khan, Mohd Ashif
    Nidhi
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 516 - 528
  • [5] Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy
    Toh, Yi Long
    Mujtaba, Juliana Shariq
    Bansal, Sumit
    Yeo, Angie
    Shwe, Maung
    Lau, Aik Jiang
    Chan, Alexandre
    PHARMACOTHERAPY, 2019, 39 (05): : 553 - 563
  • [6] Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial
    Lengacher, Cecile A.
    Reich, Richard R.
    Rodriguez, Carmen S.
    Nguyen, Anh Thy
    Park, Jong Y.
    Meng, Hongdao
    Tinsley, Sara
    Hueluer, Gizem
    Donovan, Kristine A.
    Moscoso, Manolete S.
    Bornstein, Elizabeth
    Kiluk, John
    Nidamanur, Sreenidhi
    Padgett, Lynne S.
    Lucas, Jean M.
    Fonseca, Tamela
    Joshi, Anisha
    Lin, Katherine J.
    Goodman, Matthew
    Kip, Kevin E.
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2025, 31 (01): : 75 - 91
  • [7] Longitudinal assessment of cancer-related cognitive impairment (CRCI) up to six-months post-chemotherapy with multiple cognitive testing methods in 943 breast cancer (BC) patients and controls.
    Janelsins, Michelle Christine
    Heckler, Charles E.
    Peppone, Luke Joseph
    Mohile, Supriya Gupta
    Mustian, Karen Michelle
    Ahles, Tim
    Palesh, Oxana
    O'Mara, Ann M.
    Minasian, Lori M.
    Williams, AnnaLynn
    Magnuson, Allison
    Schmidt, Karen
    Dakhil, Shaker R.
    Hopkins, Judith O.
    Morrow, Gary R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy
    Yi Long Toh
    Chia Jie Tan
    Ning Yi Yap
    Ritesh Parajuli
    Aik Jiang Lau
    Alexandre Chan
    Scientific Reports, 12
  • [9] Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy
    Toh, Yi Long
    Tan, Chia Jie
    Yap, Ning Yi
    Parajuli, Ritesh
    Lau, Aik Jiang
    Chan, Alexandre
    SCIENTIFIC REPORTS, 2022, 12 (01)